Ge Liu

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Discovery of N8: a novel IKKε inhibitor with potent anticancer activity via cytotoxicity, migration suppression, and autophagy modulation.

Discovery of N8: a novel IKKε inhibitor with potent anticancer activity via cytotoxicity, migration suppression, and autophagy modulation.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 06, 2026

4-Hydroxychalcone Inhibits Human Coronavirus HCoV-OC43 by Targeting EGFR/AKT/ERK1/2 Signaling Pathway.

4-Hydroxychalcone Inhibits Human Coronavirus HCoV-OC43 by Targeting EGFR/AKT/ERK1/2 Signaling Pathway.

Journal: Viruses

Published: June 23, 2025

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors.

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors.

Journal: Emerging microbes & infections

Published: November 12, 2024

Ammonium sulfate denatures transport medium less dependent on guanidinium isothiocyanate and enables SARS-CoV-2 RNA and antigen detection compatibility.

Ammonium sulfate denatures transport medium less dependent on guanidinium isothiocyanate and enables SARS-CoV-2 RNA and antigen detection compatibility.

Journal: Frontiers in microbiology

Published: February 11, 2024

Drug Repositioning for Hand, Foot, and Mouth Disease.

Drug Repositioning for Hand, Foot, and Mouth Disease.

Journal: Viruses

Published: October 31, 2022

Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in mice.

Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in mice.

Journal: Communications biology

Published: July 01, 2022

Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues.

Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 10, 2022

In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus.

In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus.

Journal: Virus research

Published: February 05, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026